Although infrequent, high use of short-acting beta 2 agonists was associated with more severe asthma, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice ...

By definition, agonists are drugs that bind to a cell receptor to trigger a specific reaction. The receptor in this case is the beta 2 -adrenergic receptor, which relaxes smooth muscles.

Increasing exposure to short-acting beta 2 agonist rescue or reliever medication appeared associated with greater risk for severe asthma exacerbations regardless of inhaled corticosteroid use ...

Both short-acting ß2-agonists (SABAs) and long-acting ß2-agonists (LABAs) play important—but different—roles in asthma management. There is also a difference between LABAs that are quick ...

Short-acting beta-2 agonists: Airsupra contains the short-acting beta-2 agonist albuterol. Taking it with other short-acting beta-2 agonists can raise the risk of side effects.

Teva to Present Findings on Short-Acting Beta Agonist (SABA) Use in Asthma Patients and the Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder to Help Inform Treatment ...

Patients' use of asthma medication was classified as appropriate (low doses of short-acting β-agonist and high doses of inhaled corticosteroid) or inappropriate (high doses of short-acting β-agonist ...

According to the newly published case-control study among people diagnosed with asthma or COPD, the use of inhaled short- or long-acting beta-2 agonists at least three years before Parkinson’s ...